Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males
about
Very short-term effects of the dipeptidyl peptidase-4 inhibitor sitagliptin on the secretion of insulin, glucagon, and incretin hormones in Japanese patients with type 2 diabetes mellitus: analysis of meal tolerance test data.Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study.Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation.Sitagliptin: Is It Effective in Routine Clinical Practice?Application of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptinDipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors.Sitagliptin: a review of its use in patients with type 2 diabetes mellitus.Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the (13)C Breath Test.Vildagliptin and its metabolite M20.7 induce the expression of S100A8 and S100A9 in human hepatoma HepG2 and leukemia HL-60 cells.Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.Time of effect duration and administration interval for sitagliptin in patients with kidney failure.
P2860
Q30871457-DD8D4CF6-280A-408D-BFC8-99DD21F36EC2Q33785132-C40C7AF9-0FA0-43C9-9C93-82BD72B6BF48Q34027687-47B5484D-430B-4DFC-A135-D985B42178E9Q34046207-439D5685-F2F4-4D66-BC0A-E7273428F18BQ35671855-E780F28C-9E0A-4A6A-B268-8A2EC82EFB20Q36706802-720A7687-23DB-4A13-82E2-6FABD808881BQ37067760-B81D0D11-9EAA-4BFF-8175-D12F75985507Q38017726-A6B09869-287C-4326-99EC-A070817D1947Q38177173-D6A9AD9F-6E03-48AC-B62D-89F76F6AF036Q40402261-4D26E322-74AC-4DDA-821C-4345A8F23973Q41497267-83576194-22CD-4731-B1FB-6A3ECEDD0676Q51028069-FD313041-BB41-4846-88E7-859B91BF1475Q51131443-33264F67-A9EE-4832-BBA8-FF46CBF3AEFC
P2860
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evaluation of pharmacokinetic ...... healthy, young Japanese males
@en
type
label
Evaluation of pharmacokinetic ...... healthy, young Japanese males
@en
prefLabel
Evaluation of pharmacokinetic ...... healthy, young Japanese males
@en
P2093
P2860
P1476
Evaluation of pharmacokinetic ...... healthy, young Japanese males
@en
P2093
Amy Q Wang
Arthur J Bergman
Bingming Yi
Gary A Herman
Goutam C Mistry
John A Wagner
Jon L Ruckle
Karen Snyder
Keith M Gottesdiener
P2860
P304
P356
10.1111/J.1365-2125.2010.03852.X
P407
P577
2011-03-01T00:00:00Z